# High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study

Study · id `cardio:ct-nct05585151` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05585151](<https://clinicaltrials.gov/study/NCT05585151>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05585151

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT05585151. Randomized; no masking; primary purpose treatment. Start 2022-11-09 (actual); primary completion 2024-04-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT05585151, source copy `cardio:ctgov-nct05585151-2023-12-11`, retrieved 2026-10-31)
- Started: 2022-11-09 (actual) (ClinicalTrials.gov record NCT05585151, source copy `cardio:ctgov-nct05585151-2023-12-11`, retrieved 2026-10-31)
- Primary completion: 2024-04-01 (anticipated) (ClinicalTrials.gov record NCT05585151, source copy `cardio:ctgov-nct05585151-2023-12-11`, retrieved 2026-10-31)
- Completion: 2024-10-01 (anticipated) (ClinicalTrials.gov record NCT05585151, source copy `cardio:ctgov-nct05585151-2023-12-11`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT05585151, source copy `cardio:ctgov-nct05585151-2023-12-11`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05585151-2023-12-11`, retrieved 2026-10-31)

## The registry's words

- Brief title: High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study
- Condition: Cerebral Atherosclerosis
- Intervention (Drug): Evolocumab 140 MG/ML
- Intervention (Drug): Intensive statin treatment
- Lead sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry lists this organization as the lead sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (`cardio:org-union-hospital-tongji-medical-college-huazhong-university-090806`)

## Provenance

Content hash: f3a0f351bc573b596141c5e083ac54bb861e7f206b5f0d1ea81e8b9fb87632c3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
